Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Nov 17 - Nov 22
Most people with type 2 diabetes struggle with weight, so you get a two-for-one benefit. In December 2017, the FDA approved Ozempic as a treatment for type 2 diabetes
In this population, 53% of individuals had commercial health insurance, 18% had Medicare, 11% had Medicaid, 1% had Dual (Medicare/Medicaid) coverage, and 17% had other coverage (e.g., Tricare, Veterans Affairs, or other State or local programs)
Milk thistle may be a useful complementary therapy to help manage type 2 diabetes
In commercial plans and employer groups, adoption is accelerating: a 2025 Health Affairs/KFF survey found that 43% of firms with 5,000+ employees now cover GLP-1s for weight loss, up from 28% in 2024 ( [26] ), and 57% of employers overall cover GLP-1s for weight loss according to WTW survey data ( [27] )
